Effects of Feiyanning Decoction on proliferation of lung adenocarcinoma cell line and their production of interleukin-6 and interleukin-8 induced by tumor necrosis factor-α

Journal of Chinese Integrative Medicine

Volumn 7, Issue 8, 2009, Pages 741-745

  Wang, Ju Yong ^a   Zheng, Zhan ^a   Xu, Zhen Ye ^a   Guo, Jing ^a   Su, Wan ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cytokine; Feiyanning decoction; In vitro; Lung neoplasms; Serologic pharmacology

Indexed keywords

ATRACTYLODES MACROCEPHALA EXTRACT; FEIYANNING DECOCTION; GANCHANPI; HERBA EPIMEDII BREVICORNUS; HERBACEOUS AGENT; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; NATURAL PRODUCT; RADIX ASTRAGALI MONGOLICI; REAGENT; RHIZOMA PARIDIS; RHIZOMA POLYGONATI SIBIRICI; TETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CHINESE MEDICINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GANODERMA LUCIDUM; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; LUNG ADENOCARCINOMA; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LUNG NEOPLASMS; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; SERUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 73449126209     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20090807     Document Type: Article

References (15)

1. Balkwill F, Mantovani A. Inflammation and cancer; back to Virchow? Lancet. 2001; 357(9255): 539-545.
2. Mantovani A, Aliavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454(7203): 436-444.
3. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917): 860-867.
4. Román J, Giménez A, Lluis JM, Gassó M, Rubio M, Caballeria J, Parés A, Rodés J, Fernández-Checa JC. Enhanced DNA binding and activation of transcription factors NF-kappa B and AP-1 by acetaldehyde in HEPG2 cells. J Biol Chem. 2000; 275(19): 14684-14690.
5. Xu ZY, Jin CJ, Shen DY, Li M, Zhou WD, Zhu YW, Zhang M, Deng HB, Wang ZQ, Li L, Shou WZ, Zheng Z. Clinical study on treatment of advanced non-small-cell lung cancer with Chinese herbal medicine in different stages combined with chemotherapy. Zhong-guo Zhong Xi Yi Jie He Za Zhi. 2007; 27(10): 874-878. Chinese with abstract in English.
6. Wang JY, Xu ZY. Prof essor Xu Zhenye's experience in the treatment of lung cancer. Liaoning Zhong Yi Za Zhi. 2007; 34(9): 1202-1203. Chinese.
7. Wang JY, Jin Y, Xu ZY, Zheng Z. Effects of Feiyanning Decoction on gene expression of nuclear factor-κB activated by tumor necrosis factor-α in lung adenocarci-noma cell line. J Chin Integr Med. 2009; 7(3): 249-254. English with abstract in Chinese.
8. Chen Q. Technology of research on pharmcology of tra-ditional Chinese medicine. Beijing: People's Medical Publishing House. 2000: 145. Chinese.
9. Li YK. Several issues of traditional Chinese medicine serological pharmacological experimental methods. Zhong Yao Xin Yao Yu Lin Chuang Yao Li. 1999; 10 (2): 95-98. Chinese.
10. Cho WC. Latest discoveries and trends in translational cancer research: highlights of the 2008 Annual Meeting of the American Association for Cancer Research. Technol Cancer Res Treat. 2008; 7(4): 269-277.
11. Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004; 4(1): 11-22.
12. Blackwell TS, Christman JW. The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997; 17(1): 3-9.
13. Cai Z, Chen Q, Chen J, Lu Y, Xiao G, Wu Z, Zhou Q, Zhang J. Monocyte chemo tactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo. Neoplasia. 2009; 11(3): 228-236.
14. Esfandi F, Mohammadzadeh Ghobadloo S, Basati G. Interleukin-6 level in patients with colorectal cancer. Cancer Lett. 2006; 244(1): 76-78.
15. Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Mark E, Huget P, Dirix LY. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer. 2003; 103(5): 642-646.